Vyriad Announces Oral Presentation at the 27th American Society of Gene & Cell Therapy Annual Meeting
ROCHESTER, Minn., May 6, 2024 /PRNewswire/ -- Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic…
